phrykt

Colgate Palmolive Co (CL): who owns it and who trades it

As of Nov 16, 2026, CL insiders reported 20 open-market sales worth $64.2M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Noel R. Wallace (CEO), with $36M. 7 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Colgate Palmolive

From the latest filings

Overall: more selling than buying. Insiders and Congress mostly sold. Funds and famous investors were close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns CL

2,009 funds and institutions reported CL shares worth $62.7B at the end of Q2 2026, about 86% of the company. The largest holder is BlackRock, Inc. with 8.8%.

Funds and institutions (13F) 86%Everyone else 14%

10 largest owners, by share of the company

BlackRock, Inc.8.8%
Vanguard Capital Management LLC6.6%
State Street Corp5.9%
T. Rowe Price Associates3.5%
Vanguard Portfolio Management LLC3.0%
Geode Capital Management, LLC2.9%
Morgan Stanley2.8%
First Eagle Investment Management, LLC2.1%
Bank of New York Mellon Corp1.7%
Deutsche Bank Ag\1.5%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.69.92M8.77%$6.4B-4%
Vanguard Capital Management LLC52.25M6.55%$4.8B+0%
State Street Corp47.02M5.90%$4.3B-1%
T. Rowe Price Associates27.91M3.50%$2.6B-17%
Vanguard Portfolio Management LLC24.02M3.01%$2.2B+1%
Geode Capital Management, LLC23.14M2.90%$2.1B+1%
Morgan Stanley22.07M2.77%$2B+6%
First Eagle Investment Management, LLC16.41M2.06%$1.5B+102%
Bank of New York Mellon Corp13.53M1.70%$1.2B+8%
Deutsche Bank Ag\11.75M1.47%$1.1B-1%
Norges Bank9.69M1.22%$888M–
Acadian Asset Management LLC9.10M1.14%$834M+15%
FMR LLC (Fidelity)8.98M1.13%$824M-0%
Goldman Sachs Group Inc8.57M1.08%$786M-10%
Northern Trust Corp8.47M1.06%$777M-2%
Invesco Ltd.8.33M1.04%$763M-0%
State Farm Mutual Automobile Insurance Co6.73M0.84%$617MNo change
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC6.47M0.81%$593M-5%
Amundi6.22M0.78%$570M+20%
Bank of America Corp6.19M0.78%$567M-7%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, CL insiders reported $0 of open-market purchases and $64.2M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$64.2M
20 trades, 9 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Nov 10, 2026
Filed Nov 12, 2026

Purchases and sales by month

$31M$31MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 10, 2026Gregory MalcolmVice presidentSale4,100$97.97$402KForm 4
Nov 5, 2026Lorrie M NorringtonDirectorSale4,170$99.31$414KForm 4
Nov 5, 2026Noel R. WallaceCEOSale20,000$100.26$2MForm 4
Nov 4, 2026John HazlinChief Growth OfficerSale23,376$99.15$2.3MForm 4
Nov 4, 2026Panagiotis TsourapasCOOSale19,938$98.74$2MForm 4
Aug 24, 2026Panagiotis TsourapasCOOSale10,000$92.05$920KForm 4
Aug 6, 2026John T CahillDirectorSale4,170$93.37$389KForm 4
Aug 5, 2026Noel R. WallaceCEOSale161,021$92.52$14.9MForm 4
Aug 4, 2026Noel R. WallaceCEOSale161,021$91.92$14.8MForm 4
May 15, 2026Gregory MalcolmVice presidentSale2,300$88.44$203KForm 4
May 7, 2026Sally MasseyChief People OfficerSale8,599$87.41$752KForm 4
Feb 12, 2026Panagiotis TsourapasCOOSale15,000$97.81$1.5MForm 4
Feb 11, 2026Panagiotis TsourapasCOOSale35,000$94.61$3.3MForm 4
Feb 10, 2026John HazlinChief Growth OfficerSale20,989$94.25$2MForm 4
Feb 6, 2026Gregory MalcolmVice presidentSale12,747$94.91$1.2MForm 4
Feb 5, 2026Sally MasseyChief Human Resources OfSale15,851$95.03$1.5MForm 4
Feb 4, 2026Stanley J Sutula IIICFOSale97,843$94.27$9.2MForm 4
Feb 4, 2026Jennifer DanielsCLO and SecretarySale22,000$94.34$2.1MForm 4
Feb 4, 2026Noel R. WallaceCEOSale45,568$93.91$4.3MForm 4
Nov 21, 2025Sally MasseyChief Human Resources OfSale1,237$80.89$100KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Noel R. WallaceChairman, President & CEO, Director–$36MNov 5, 2026
Stanley J Sutula IIIChief Financial Officer–$9.2MFeb 4, 2026
Panagiotis TsourapasCOO, Eur., APac, Afr Eur, Skin–$7.7MNov 4, 2026
John HazlinChief Growth Officer–$4.3MNov 4, 2026
Sally MasseyChief Human Resources Officer–$2.4MMay 7, 2026
Jennifer DanielsCLO and Secretary–$2.1MFeb 4, 2026
Gregory MalcolmEVP and Controller–$1.8MNov 10, 2026
Lorrie M NorringtonDirector–$414KNov 5, 2026
John T CahillDirector–$389KAug 6, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

CL short interest

Low short interest. 2.3% of CL shares are sold short: about 1 share in 43. Over the last 12 reports the number of shares short went down 7%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 18.54M CL shares were sold short, 2.3% of the shares outstanding, up 6.5% from the report before. At the average daily volume of 4.95M shares, buying them all back would take about 3.8 trading days (days to cover).

Shares short, % of all shares

2.33%May 15Oct 303.16%

Days to cover

3.8May 15Oct 304.4

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202618.54M2.33%+7%4.95M3.8
Oct 15, 202617.41M2.19%-28%4.93M3.5
Sep 30, 202624.04M3.02%+31%6.00M4.0
Sep 15, 202618.40M2.31%+7%4.61M4.0
Aug 31, 202617.17M2.15%-2%4.12M4.2
Aug 14, 202617.56M2.20%-1%4.34M4.0
Jul 31, 202617.77M2.23%+6%4.63M3.8
Jul 15, 202616.72M2.10%-5%4.33M3.9
Jun 30, 202617.53M2.20%-15%6.12M2.9
Jun 15, 202620.53M2.57%-3%5.43M3.8
May 29, 202621.14M2.64%+7%5.09M4.2
May 15, 202619.84M2.48%+15%5.39M3.7

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded CL

Since Nov 17, 2024, 7 members of Congress reported 3 purchases and 12 sales of CL. The latest was a sale by Kevin Hern on Sep 2, 2026, reported Sep 25, 2026.

Purchases 3Sales 12

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Sep 2, 2026Kevin Hern (R-OK)Partial sale$1K–$15KJointSep 25, 2026Report
Aug 31, 2026Kevin Hern (R-OK)Sale$1K–$15KSelfSep 25, 2026Report
Aug 27, 2026Kevin Hern (R-OK)Partial sale$1K–$15KSelfSep 25, 2026Report
Aug 19, 2026Kevin Hern (R-OK)Sale$1K–$15KJointSep 1, 2026Report
Oct 6, 2025Rick Larsen (D-WA)Sale$1K–$15KSelfOct 16, 2025Report
Sep 25, 2025Julie Johnson (D-TX)Sale$1K–$15KJointOct 7, 2025Report
Sep 23, 2025Julie Johnson (D-TX)Sale$1K–$15KJointAug 5, 2026Report
Sep 23, 2025Julie Johnson (D-TX)Purchase$1K–$15KJointAug 5, 2026Report
Sep 11, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseOct 22, 2025Report
Sep 10, 2025Tim Moore (R-NC)Sale$1K–$15KSelfOct 10, 2025Report
Aug 13, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseSep 12, 2025Report
Jul 31, 2025Shelley Moore Capito (R-WV)Sale$1K–$15KSpouseAug 4, 2025Report
Jul 11, 2025Ritchie Torres (D-NY)Sale$1K–$15KSelfAug 20, 2025Report
Jun 24, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseAug 13, 2025Report
Jun 17, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseAug 13, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Colgate Palmolive company events

Colgate Palmolive filed 8 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership, job cuts). The latest was on Oct 30, 2026.

  1. Oct 30, 2026ResultsReleased financial results. Filing
  2. Jul 31, 2026ResultsReleased financial results. Filing
  3. May 13, 2026VoteReported shareholder vote results. Filing
  4. May 1, 2026Job cutsAnnounced job cuts or other exit costs. Filing
  5. Apr 9, 2026LeadershipJennifer M. Daniels, who has served as Chief Legal Officer and Secretary of Colgate-Palmolive Company since 2014, has communicated to the Company her intention to retire from the Company in 2026. Filing
  6. Mar 17, 2026AnnouncementAs part of the previously announced Strategic Growth and Productivity Program, to further optimize and leverage the operating scale and drive growth within the Europe and Africa/Eurasia regions, effective for the quarter ending March 31, 2026, Colgate-Palmolive Company has realigned its reportable… Filing
  7. Mar 12, 2026LeadershipThe Board of Directors of Colgate-Palmolive Company elected Christopher S. Boerner, Ph.D., Board Chair and Chief Executive Officer of Bristol-Myers Squibb Company, to the Colgate-Palmolive Board, effective March 15, 2026. Filing
  8. Jan 30, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Colgate Palmolive financials

Famous investors that hold CL

7 of the 50 well-known investors we track reported holding CL in their latest 13F filing. The largest position is Jim Simons's, worth $140M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 20261.64M$140M0.2%+86%
Israel Englander · Millennium ManagementQ3 2026664,778$56.7M0.0%-48%
Ken Griffin · Citadel AdvisorsQ3 2026510,582$43.6M0.0%-89%
Ken Fisher · Fisher Asset ManagementQ3 2026100,653$8.6M0.0%+64%
Paul Tudor Jones · Tudor Investment CorpQ3 202666,553$5.7M0.0%New
Ray Dalio · Bridgewater AssociatesQ3 202647,550$4.1M0.0%-38%
Jeremy Grantham · GMOQ3 202631,342$2.7M0.0%-43%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Colgate Palmolive Co (CL) stock

Who owns the most CL stock?

The largest reported owner of Colgate Palmolive Co (CL) is BlackRock, Inc., with 8.8% of the company. In total, 2,009 funds and institutions reported holding CL at the end of Q2 2026, together about 86% of the shares. See the largest owners.

Are CL insiders buying or selling?

In the last 12 months, CL insiders reported no open-market purchases and 20 sales worth $64.2M. The latest trade was on Nov 10, 2026. See every trade.

What is the short interest in CL?

As of Oct 30, 2026, 18.54M CL shares were sold short, 2.3% of the shares outstanding, up 6.5% from the report before. At the average daily volume of 4.95M shares, buying them all back would take about 3.8 trading days (days to cover). See the history.

Have members of Congress traded CL?

Yes. 7 members of Congress reported 3 purchases and 12 sales of CL since Nov 17, 2024. The latest was reported on Sep 25, 2026. See the trades.

Which famous investors hold CL?

7 of the 50 well-known investors we track reported CL in their latest 13F filing, including Jim Simons, Israel Englander, Ken Griffin. The largest position is worth $140M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.